These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7969954)

  • 21. The sensitivity and specificity of anti-GM1 antibody testing.
    Taylor BV; Gross L; Windebank AJ
    Neurology; 1996 Oct; 47(4):951-5. PubMed ID: 8857725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin infusion in multifocal demyelinating motor neuropathy: a case report.
    Lin YY; Tsai CP; Ting YC; Lin KP; Liao KK; Kao KP; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jul; 56(1):66-9. PubMed ID: 7553414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifocal motor neuropathy.
    Nobile-Orazio E
    J Neuroimmunol; 2001 Apr; 115(1-2):4-18. PubMed ID: 11282149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a.
    Kaji R; Kusunoki S; Mizutani K; Oka N; Kojima Y; Kohara N; Kimura J
    Muscle Nerve; 2000 May; 23(5):702-6. PubMed ID: 10797392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
    Pestronk A; Choksi R; Blume G; Lopate G
    Neurology; 1997 Apr; 48(4):1104-6. PubMed ID: 9109910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal motor neuropathy: current concepts and controversies.
    Nobile-Orazio E; Cappellari A; Priori A
    Muscle Nerve; 2005 Jun; 31(6):663-80. PubMed ID: 15770650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor neuropathies and antiglycolipid antibodies.
    Serratrice G
    Clin Exp Neurol; 1993; 30():25-32. PubMed ID: 7712626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower motor neuron syndrome associated with anti-GM1 antibodies.
    Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
    Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocal motor neuropathy with conduction block: current issues in diagnosis and treatment.
    Nagale SV; Bosch EP
    Semin Neurol; 2003 Sep; 23(3):325-34. PubMed ID: 14722828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.
    Toscano A; Rodolico C; Benvenga S; Girlanda P; Laurà M; Mazzeo A; Nobile-Orazio E; Trimarchi F; Vita G; Messina C
    Neuromuscul Disord; 2002 Aug; 12(6):566-8. PubMed ID: 12117481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of multifocal motor neuropathy with IgM lambda anti-GM1 antibody and IgM kappa paraprotein reacting exclusively with GM2].
    Arai M; Kusunoki S
    Rinsho Shinkeigaku; 2009; 49(2-3):123-6. PubMed ID: 19348179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative trial of anti-glycoconjugate antibody assays: IgM antibodies to GM1.
    Zielasek J; Ritter G; Magi S; Hartung HP; Toyka KV
    J Neurol; 1994 Jul; 241(8):475-80. PubMed ID: 7964915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different patterns of glycolipid antibody reactivity: lower motor neuron syndromes vs. immunization.
    Chaudhry V; Pestronk A
    J Neuroimmunol; 1992 Feb; 36(2-3):127-34. PubMed ID: 1732278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower motor neuron disease in a patient with autoantibodies against Gal(beta 1-3)GalNAc in gangliosides GM1 and GD1b: improvement following immunotherapy.
    Shy ME; Heiman-Patterson T; Parry GJ; Tahmoush A; Evans VA; Schick PK
    Neurology; 1990 May; 40(5):842-4. PubMed ID: 2330115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The spectrum of neurologic disease associated with anti-GM1 antibodies.
    Sadiq SA; Thomas FP; Kilidireas K; Protopsaltis S; Hays AP; Lee KW; Romas SN; Kumar N; van den Berg L; Santoro M
    Neurology; 1990 Jul; 40(7):1067-72. PubMed ID: 2162499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.